Fri, June 25, 2021
NEWS AND STOCK MARKET DATA FROM THE CANNABIS INDUSTRY
GW Pharmaceuticals
GW Pharmaceuticals
Symbol:  GWPRF (OTCMKTS)
https://www.gwpharm.com

GW Pharmaceuticals is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz Pharmaceuticals.
Read more at Wikipedia.  Wikipedia content reproduced under a Creative Commons BY-SA license.

Leave your comments about this company:
Your Name: Comment:
500 characters